Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AtriCure (ATRC) Other Operating Expenses (2018 - 2023)

AtriCure (ATRC) has disclosed Other Operating Expenses for 7 consecutive years, with $60.7 million as the latest value for Q2 2023.

  • On a quarterly basis, Other Operating Expenses changed N/A to $60.7 million in Q2 2023 year-over-year; TTM through Mar 2024 was $60.7 million, a N/A change, with the full-year FY2021 number at -$102.5 million, down 28611.48% from a year prior.
  • Other Operating Expenses was $60.7 million for Q2 2023 at AtriCure, up from $5.1 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $60.7 million in Q2 2023 to a low of -$107.6 million in Q3 2021.
  • A 4-year average of -$9.3 million and a median of -$178500.0 in 2020 define the central range for Other Operating Expenses.
  • Peak YoY movement for Other Operating Expenses: surged 132.44% in 2020, then crashed 2116.73% in 2021.
  • AtriCure's Other Operating Expenses stood at -$13.9 million in 2019, then soared by 132.44% to $4.5 million in 2020, then grew by 13.41% to $5.1 million in 2021, then soared by 1090.1% to $60.7 million in 2023.
  • Per Business Quant, the three most recent readings for ATRC's Other Operating Expenses are $60.7 million (Q2 2023), $5.1 million (Q4 2021), and -$107.6 million (Q3 2021).